We were inspired by a previous study, in which CRP levels ≥10 mg/L or a clinical score ≥5 (the Harvey–Bradshaw index for CD and the Simple Clinical Colitis Activity Index for UC) predicted a nearly fourfold increased risk of steroid therapy or surgery after the 14-week induction therapy period [23]. The gene discussed is CRP; the disease is colitis.